Wed Sep 03 04:30:00 UTC 2025: Okay, here’s a news article summarizing the provided text about the Amanta Healthcare IPO:

**Headline: Final Day for Amanta Healthcare IPO as Demand Soars, GMP Suggests Strong Listing**

**Mumbai, September 2, 2025** – Investors have just one day left to subscribe to the Amanta Healthcare IPO, which closes tomorrow, September 3, 2025. The initial public offering, aiming to raise ₹126 crore through the issuance of fresh shares, has seen robust demand, being subscribed 19.62 times overall by the end of its second day.

The retail portion of the IPO has been particularly popular, subscribed 23.33 times, while the Non-Institutional Investor (NII) segment saw a subscription rate of 36.40 times. The Qualified Institutional Buyer (QIB) portion was subscribed 0.53 times.

The company has set the price band at ₹120 to ₹126 per equity share. Market observers are reporting a Grey Market Premium (GMP) of ₹29 per share today, a slight increase from yesterday’s ₹28. This GMP suggests a potential listing price approximately 22% above the upper end of the IPO price band.

“Amanta Healthcare’s IPO GMP rose from ₹26 to ₹29 in the first two days of bidding, which could become possible due to the strong response of investors and cautious but positive sentiments in the secondary market.”

Investment firms are offering mixed views. Invest4Edu advises investors to apply, citing the company’s strong position in the growing market for sterile liquid pharmaceuticals and medical devices, along with its advanced manufacturing technologies and diverse product portfolio. They highlight the company’s focus on its SteriPort brand and plans for capacity expansion.

However, Scoop Investment recommends a “Subscribe for Long Term” rating, noting that while the IPO valuation of 46x FY25 earnings appears elevated, it is expected to moderate as the company reduces debt and expands earnings with the help of funds raised through IPO. It added that any execution delays in capex or deleveraging could, however, impact this trajectory.

The proceeds from the IPO will go entirely into the company’s balance sheet and are intended for capacity expansion. Amanta Healthcare’s shares are proposed to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Investors are advised to consult with certified experts before making any investment decisions.

Read More